SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-027454
Filing Date
2017-04-19
Accepted
2017-04-19 16:18:54
Documents
2
Period of Report
2017-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1493
2 EX-24 DOCUMENT attachment1.htm EX-24 4658
  Complete submission text file 0001209191-17-027454.txt   7530
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
VESSEY RUPERT (Reporting) CIK: 0001677618 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36781 | Film No.: 17770185